WealthPlan Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,807
Closed -$204K 353
2025
Q1
$204K Buy
+1,807
New +$193K 0.02% 259
2024
Q2
Sell
-1,903
Closed -$251K 199
2024
Q1
$251K Buy
1,903
+3
+0.2% +$375 0.04% 168
2023
Q4
$231K Sell
1,900
-25
-1% -$2.79K 0.04% 175
2023
Q3
$216K Buy
1,925
+102
+6% +$13K 0.04% 163
2023
Q2
$265K Sell
1,823
-97
-5% -$13.2K 0.08% 120
2023
Q1
$248K Sell
1,920
-270
-12% -$33.9K 0.04% 149
2022
Q4
$280K Buy
2,190
+3
+0.1% +$348 0.02% 329
2022
Q3
$272K Buy
+2,187
New +$240K 0.02% 308
2022
Q1
$252K Buy
+2,091
New +$252K 0.02% 344

Other funds holding ZBH

WealthPlan Investment Management's ZBH Position: Q2 2025 in Review

WealthPlan Investment Management sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 1,807 shares — an estimated $204K sold.

WealthPlan Investment Management first reported a position in ZBH in Q1 2022 and held it in 9 quarters. The position peaked at $280K in Q4 2022. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • WealthPlan Investment Management reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • WealthPlan Investment Management sold 1,807 Zimmer Biomet shares in Q2 2025, an estimated $204K.
  • WealthPlan Investment Management first reported a position in Zimmer Biomet in Q1 2022 and held it in 9 quarters.
  • WealthPlan Investment Management's Zimmer Biomet position peaked at $280K in Q4 2022.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on WealthPlan Investment Management's 13F filing for Q2 2025, filed 28 Jul 2025.